Frontlight ResearchEarly access
Trial site
Institut de Recherche en Cancérologie de Montpellier (IRCM)
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer1 trial
- Neuroendocrine tumours1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Daiichi Sankyo1 trial
- ITM Solucin GmbH1 trial
Running trials
Active, not recruiting
Active, not recruiting
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Site data: ClinicalTrials.govUpdated 12 Nov 2026